DSM-Firmenich AGXSWX:DSFIR +5.62%32 EBITDA Margin % is 97.54% as of Dec. 2025, which is 620% above its 10-year median of 13.55. GuruFocus rates XSWX:DSFIR with a GF Score™ of 32/100 and a GF Value™ of CHF70.90 (Fairly Valued). The stock has 5 warning signs investors should review. Among 1,584 Chemicals companies, DSM-Firmenich AG ranks better than 97.47% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. DSM-Firmenich AG's EBITDA for the
six
months ended in Dec. 2025 was CHF2,297 Mil. DSM-Firmenich AG's Revenue for the
six
months ended in Dec. 2025 was CHF2,355 Mil. Therefore, DSM-Firmenich AG's EBITDA margin for the quarter that ended in Dec. 2025 was 97.54%.
DSM-Firmenich AG (XSWX:DSFIR) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
DSM-Firmenich AG EBITDA Margin % Related Terms
DSM-Firmenich AG EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for DSM-Firmenich AG's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:DSFIR vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, DSM-Firmenich AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DSM-Firmenich AG EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, DSM-Firmenich AG's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where DSM-Firmenich AG's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DSM-Firmenich AG (XSWX:DSFIR) has a EBITDA Margin % of 97.54% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on DSM-Firmenich AG and its competitors. This is 620% above median its historical median of 13.55. Over the past decade, DSM-Firmenich AG's EBITDA Margin % has ranged from 4.71 to 42.61. According to the industry distribution chart, DSM-Firmenich AG ranks #40 out of 1584 companies in the Chemicals industry, placing it in the top 2.5%.
Is DSM-Firmenich AG's EBITDA Margin % too high?
DSM-Firmenich AG's current EBITDA Margin % of 97.54% is 620% above median its 10-year median of 13.55. Over the past 10 years, this metric has ranged from a low of 4.71 to a high of 42.61. The Chemicals industry median EBITDA Margin % is 9.64. DSM-Firmenich AG's value of 97.54% is 912.4% above this industry median. Based on the distribution chart, DSM-Firmenich AG ranks #40 out of 1584 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, DSM-Firmenich AG has a GF Score™ of 32/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, DSM-Firmenich AG ranks #40 out of 1584 companies for EBITDA Margin %. This places DSM-Firmenich AG in the top 3% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.64. DSM-Firmenich AG's value of 97.54% is 912.4% above this benchmark. Historically, DSM-Firmenich AG's own EBITDA Margin % has ranged from 4.71 to 42.61 over the past decade. While the company's 10-year median is 13.55 vs. the industry median of 9.64, DSM-Firmenich AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,584 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DSM-Firmenich AG's current EBITDA Margin % of 97.54% is 912.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on DSM-Firmenich AG and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DSM-Firmenich AG's current EBITDA Margin % is 97.54%, which is 620% above median its own 10-year median of 13.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (XSWX:DSFIR) is currently considered Fairly Valued. The stock's GF Value™ is CHF70.90, compared to a current price of CHF74.82 — trading 5.5% above its estimated fair value. The current EBITDA Margin % is 97.54%, which is 620% above median its 10-year median of 13.55 and 912.4% above the Chemicals industry median of 9.64. DSM-Firmenich AG's overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For DSM-Firmenich AG (XSWX:DSFIR), the current EBITDA Margin % is 97.54% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DSM-Firmenich AG (XSWX:DSFIR) Overvalued in 2026?
Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued.
The current stock price of CHF74.82 is trading 5.5% above its estimated GF Value™ of CHF70.90.
GuruFocus considers DSM-Firmenich AG to be Fairly Valued.
Key valuation signals for XSWX:DSFIR:
EBITDA Margin %: 97.54% (620% above median its 10-year median of 13.55)
GF Value™: CHF70.90 vs. price of CHF74.82 (5.5% above fair value)
Industry Position: 912.4% above the Chemicals median (#40 of 1584)
No single metric tells the full story. See the XSWX:DSFIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
32GF Score
Get the complete analysis for XSWX:DSFIR
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DSFIR has been successfully added to your 